A respiratory delivery specialist company was looking at established drugs to assess the attractiveness and risks of developing inhaled or intranasal formulations of selected molecules. It had already filtered a long list of 100 potential projects to 50 and requested Alacrita's support from a pharmaceutical physician in order to winnow these down to a shortlist. In addition, the client requested biostatistical support to help develop suitable trial designs for selected projects.
One of Alacrita's experienced pharmaceutical physicians integrated into the client's team to further the prioritization of the R&D options. Our statistician followed up with an assessment of trial design options and the associated analytical frameworks.
Our drug development consultants bring an average of 20 years of industry experience and wisdom to our clients' program teams. Many have made significant contributions to the development of launched products and have held global responsibilities for marketed medicines. With Alacrita, you can access high-caliber, clinical development experts with proven track records and precisely relevant expertise.
Learn more